« MediaWiki:ContentImporter-wikidoc-postponed.json » : différence entre les versions
|
|
| Ligne 24 : |
Ligne 24 : |
| "21-Hydroxylase Deficiency social issues", | | "21-Hydroxylase Deficiency social issues", |
| "Neuritis", | | "Neuritis", |
| "List of endocrine diseases" | | "List of endocrine diseases", |
| | "Abdominal epilepsy" |
| ] | | ] |
Version du 4 octobre 2019 à 14:27
| "(-)-1-Phenyl-2-propylaminopentane" |
| "(-)-1-phenyl-2-propylaminopentane" |
| "(-)-2β-Carbomethoxy-3β-(3,4-dichlorophenyl)tropane" |
| "(-)-2β-Carbomethoxy-3β-(4-fluorophenyl)tropane" |
| "(-)-2β-Carbomethoxy-3β-(4-iodophenyl)tropane" |
| "(-)-2β-Carbomethoxy-3β-phenyltropane" |
| "(-)-Methyl-1-methyl-4β-(2-naphthyl)piperidine-3β-carboxylate" |
| "11β-hydroxylase deficiency (patient information)" |
| "Abadie's sign of tabes dorsalis" |
| "Abdominal enlargement" |
| "Abdominal pain" |
| "Acanthosis nigricans" |
| "Accommodative insufficiency" |
| "Acid indigestion" |
| "Acute muscle soreness" |
| "Ankle pain and swelling" |
| "Anosmia" |
| "Anxiety" |
| "Abdominal bruit" |
| "16PF Questionnaire" |
| "16 Personality Factors" |
| "1p36 deletion syndrome" |
| "21-Hydroxylase Deficiency social issues" |
| "Neuritis" |
| "List of endocrine diseases" |
| "Abdominal epilepsy" |
|
